Deep Track entities acquire LBRX shares at $15 and convert Series C preferred
Rhea-AI Filing Summary
Deep Track reporting persons disclosed multiple transactions in LB PHARMACEUTICALS INC (LBRX) dated 09/12/2025. Series C preferred shares converted immediately prior to the issuer's IPO, producing common stock on a conversion ratio tied to the IPO price. Deep Track Biotechnology Master Fund, Ltd. reported receipt of 686,138 common shares from conversion. The reporting persons also acquired 2,000,000 common shares and 666,666 common shares by purchase at $15.00 per share. After these transactions, Deep Track Biotechnology Master Fund, Ltd. beneficially owned 2,686,138 shares directly and Deep Track Special Opportunities Fund, LP held 666,666 shares indirectly.
Positive
- Acquisition of large share blocks: purchases of 2,000,000 and 666,666 common shares at $15.00 each
- Conversion to common stock: Series C preferred converted resulting in 686,138 common shares
- Clear disclosure of relationships: filers provide managerial links and disclaimers for indirect ownership
Negative
- No negative items explicitly disclosed
Insights
TL;DR: Significant insider purchases and conversion increased Deep Track entities' common shareholdings ahead of or concurrent with the issuer's IPO.
The Form 4 shows a mix of conversion and open-market purchases on 09/12/2025: a conversion of Series C preferred into 686,138 common shares and purchases totaling 2,666,666 common shares at $15.00 each. These transactions raise the reporting persons' direct beneficial ownership to 2,686,138 shares and add an indirect holding of 666,666 shares via Deep Track Special Opportunities Fund, LP. From a capital-structure perspective, the conversion of Series C preferred increased common float by the converted amount; purchase prices are explicitly disclosed as $15.00 per share.
TL;DR: Reporting structure and disclaimers clarify indirect ownership and managerial relationships without admitting broader beneficial ownership.
Filers disclose typical managerial relationships: Deep Track Capital, LP is the investment manager of the funds and David Kroin is the managing member of the general partner. The filing includes standard disclaimers that Deep Track Capital, LP and Mr. Kroin disclaim beneficial ownership except to their pecuniary interests. The Form 4 is signed by the relevant parties on 09/16/2025, and the Explanation clarifies that conversions occurred immediately prior to the issuer's IPO closing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series C Preferred Stock | 16,666,667 | $0.00 | -- |
| Conversion | Common Stock | 686,138 | $0.00 | -- |
| Purchase | Common Stock | 2,000,000 | $15.00 | $30.00M |
| Purchase | Common Stock | 666,666 | $15.00 | $10.00M |
Footnotes (1)
- Each share of Series C Preferred Stock automatically converted immediately prior to the closing of the Issuer's initial public offering for no additional consideration at a conversion ratio that was dependent upon the initial price per share to the public in the Issuer's initial public offering. Represents securities held by Deep Track Biotechnology Master Fund, Ltd. Deep Track Capital, LP is the investment manager of Deep Track Biotechnology Master Fund, Ltd. Mr. David Kroin is the managing member of Deep Track Capital GP, LLC, the general partner of Deep Track Capital, LP., and by virtue of such status may be deemed to be the beneficial owner of the shares owned by Deep Track Biotechnology Master Fund, Ltd. Deep Track Capital, LP and Mr. Kroin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests. Represents securities held by Deep Track Special Opportunities Fund, LP. Deep Track Capital, LP is the investment manager of Deep Track Special Opportunities Fund LP. Mr. David Kroin is the managing member of Deep Track Capital GP, LLC, the general partner of Deep Track Capital, LP., and by virtue of such status may be deemed to be the beneficial owner of the shares owned by Deep Track Special Opportunities Fund, LP. Deep Track Capital, LP and Mr. Kroin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests.
